Capecitabine and oxaliplatin in combination as first or second-line therapy for metastatic breast cancer: A Wisconsin Oncology Network trial

PURPOSE: Several cytotoxic chemotherapy regimens are active against metastatic breast cancer; however, benefits are modest and overall prognosis remains limited. For anthracycline and taxane-pretreated metastatic breast cancer, there remains a relative paucity of therapies with significant activity....

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Njiaju, U.O., Tevaarwerk, A.J., Kim, K., Chang, J.E., Hansen, R.M., Champeny, T.L., Traynor, A.M., Meadows, S., Van Ummersen, L., Powers, K., Stewart, J.A.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2012
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3581759/
https://ncbi.nlm.nih.gov/pubmed/23228989
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-012-2044-2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares